The introduction of pharmaceutical product patents in India and other developing countries is expected to have a significant effect on public health and local pharmaceutical industries. This paper draws implications from the historical experience of Japan when it introduced product patents in 1976. In Japan, narrow patents and promotion of cross-licensing were effective tools to keep drug prices in check while ensuring the introduction of new drugs. While the global pharmaceutical market surrounding India today differs considerably from that of the 1970's, the Japanese experience offers a policy option that may profitably be considered by India today. The Indian patent system emphasizes the patentability requirement in contrast to the Japanese patent policy which relied on narrow patents and extensive licensing. R&D by local firms and the development of local products may be promoted more effectively under the Japanese model.
権利
Copyrights 日本貿易振興機構（ジェトロ）アジア経済研究所 / Institute of Developing Economies, Japan External Trade Organization (IDE-JETRO) http://www.ide.go.jp
雑誌名
IDE Discussion Paper
雑誌名(英)
IDE Discussion Paper
巻
57
発行年
2006-03-01
出版者
Institute of Developing Economies (IDE-JETRO)
著者版フラグ
publisher
日本十進分類法
507.23
JEL分類
JEL:I11 - Analysis of Health Care Markets
JEL:I18 - Government Policy; Regulation; Public Health
JEL:L50 - General
JEL:L65 - Chemicals; Rubber; Drugs; Biotechnology
JEL:O10 - General
JEL:O31 - Innovation and Invention: Processes and Incentives
JEL:O34 - Intellectual Property Rights
地域/国名
日本
インド
キーワード(LSH)
Pharmaceutical industry
Industrial policy
Intellectual property rights
Patent law
Public health
Industrial property law
India
Japan
製薬業
産業政策
知的所有権
特許法
公衆衛生
工業所有権法
インド
日本
Indian Patent Policy and Publich Health : implications from the Japanese Experience
本文
(196.02KB)
